June 6, 2025PFIZER INC. PFE Partners with Acepodia, Innovating Cancer Treatments ~1 min.Pfizer Inc. announced a new partnership with Acepodia to develop cutting-edge cancer treatments....
April 4, 2025PFIZER INC. Hits Forecast Price Target with 7.0% Profit - QuantWave Analysis ~1 min.PFIZER INC. has successfully achieved the price target forecast set by QuantWave, with a profit of 7.0%. The forecast signal was issued on April 2, 2025, at a price of 24.24 $....
April 3, 2025PFIZER INC. Hits Price Target Forecast with 7.05% Profit ~1 min.QuantWave's forecast for PFIZER INC. proved to be successful as the stock reached the predicted target price of 23.84 $ on April 3, 2025, from the initial signal date of May 7, 2024, when the price was at 25....
March 27, 2025With 67 ownership Pfizer Inc. NYSE:PFE boasts of strong institutional backing ~1 min.Pfizer Inc., a renowned pharmaceutical company, is currently enjoying the support of strong institutional investors with a significant 67% ownership....
March 21, 2025Analyst Says Pfizer PFE Stock Will Move Too Fast to Catch ~1 min.According to recent analysis by Stocks Prognosis, Pfizer Inc. (NYSE:PFE) is expected to experience significant movement in its stock price in the near future....
April 8, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target with 20% Profit: QuantWave Analysis ~1 min.In a recent success for QuantWave's forecasting platform, the stock of REGENERON PHARMACEUTICALS, INC. has hit its price target with a 20% profit margin....
August 15, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 19.37% Profit: QuantWave Analysis ~1 min.REGENERON PHARMACEUTICALS, INC. has achieved the price target forecast set by QuantWave, resulting in a profit of 19.37%....
April 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with Profit of 15.56% ~1 min.REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave on April 4, 2025....
May 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with a Profit of 30.6% ~1 min.REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecasted by QuantWave, resulting in a profit of 30.6% for investors who followed the short signal....
September 10, 2024ABBVIE INC. Hits Price Target Forecast with 17.82% Profit: QuantWave Success Story ~1 min.On July 16, 2024, QuantWave, an automated forecasting platform, made a significant prediction for ABBVIE INC. with a long signal at a price of $164.77....
